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Abstract:
Background: Brucellosis is an important zoonotic disease in developing countries yet it is often not recognized, 
goes unreported and does not attract public health action by these governments including Uganda.
Objective: To estimate the sero-prevalence and assess modifiable risk factors associated with Brucella seropositiv-
ity in cattle keepers and consumers of  unpasteurized milk in Uganda. 
Methods: One group comprised of  161 individuals randomly selected from households living on farms that had 
Brucella sero-positive cattle and/or goats in Mbarara District from an earlier survey; the second group comprised 
of  168 randomly selected individuals attending an HIV voluntary counseling and testing clinic in Kampala District. 
Sera samples were tested using Rapid Plate Agglutination Test, Standard Tube Agglutination Test and cELISA.
Results:  The  sero-prevalence  of   brucellosis  among  exposed  cattle  keepers  in  Mbarara  and
consumers of  unpasteurised milk in Kampala Districts was 5.8% (95%CI: 3.3%, 8.3%) and 9% (95%CI: 13.3%, 
4.7%), respectively. Consumption of  unboiled milk was significantly (p=0.004) associated  with  seropositivity in 
Mbarara  District. There  was  no  association  between  sero- positivity with age, sex and awareness of  human 
brucellosis.
Conclusion:  Human  brucellosis  is  prevalent  among  livestock  rearing  communities  and consumers of  un-
pasteurised milk. The continued consumption of  unboiled milk is a major health risk.
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Introduction
Brucellosis also known as Malta fever or undulant fever 
for the disease  in humans1 is among the most common 
and important zoonotic disease globally especially in 
developing countries yet it often is not recognized, goes 
unreported and does not attract public health action by 
these governments2, 3.  
There are six known species with numerous biotypes. 
Brucella  abortus, and B. melitensis  cause disease in 
cattle, pigs sheep and, goats,respectively, resulting in im-
portant economic losses. Although B. melitensis is the 
most pathogenic for humans, Brucella species show 
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cross-species infection particularly with B. melitensis 
(Corbel et al., 2006)3.
 Humans   usually   acquire   brucellosis   through   con-
tact   with   infected   animals   or consumption  of  
contaminated  milk  or  milk  products4.  Although  B. 
melitensis  is  the  most pathogenic compared to B. 
abortus for humans, the consumption of  goat milk in 
Uganda is not common5 (Ndyabahinduka et al, 1978). 
Brucellosis is also recognized as an occupational haz-
ard for farmers, veterinarians, and workers in the meat 
industry in areas with enzootic B.  abortus and/ or B. 
melitensis.  
A recent study among abattoir workers in Uganda re-
ported a brucella seropositivity of  10% (95%CI: 6–16; 
n=232)6  (Nabukenya et al, 2013).  Symptoms of  acute
brucellosis caused by B. abortus and /or B. melitensis 
are flu-like and are highly non-specific. Chronic brucel-
losis is an insidious disease with vague symptoms that 
might be confused with other diseases affecting various 
organ systems5,7. The varied and sometimes deceptive 
African Health Sciences Vol 14 Issue 4, December 2014
manifestation of  localized, sub-acute or chronic infec-
tions may lead to miss-diagnosis or delayed diagnosis 
if  the attending clinician has a low index of  suspicion. 
The disease is a zoonosis of  worldwide distribution and 
a common cause of  economic loss and ill health among 
animals and human  populations.  Although  the  inci-
dence  of   brucellosis  has  decreased  significantly  in 
developed countries6,8, the disease remains a major pub-
lic health threat in many developing countries including 
Uganda7, 8, 9,10.
In  Uganda,  the  disease  in  animals  remains  a  pri-
vate   matter with good  with  control   measures either-
measures  either  lacking  or  difficult  to  implement. 
Brucellosis  cases  in  the  human population largely go 
un-noticed probably because the disease is not among 
those routinely screened  for  in  health  centers  in 
Uganda.  Consequently  there  is  poor  knowledge,  if  
any concerning the prevalence and epidemiology of  this 
disease in the human population in Uganda. To date 
there is no comprehensive study to high light the sta-
tus of  human brucellosis in Uganda. This study sought 
to establish the sero-prevalence of  Brucella antibodies 
among exposed cattle keepers in Mbarara district where 
brucellosis is known to be endemic among livestock,9, 10 
11,12 among consumers of  un-pasteurized milk in Kam-
pala district, and also to identify modifiable risk factors 
for the disease.
Methods
Sampling and sample size determination
The study population was comprised of  two groups. 
One group consisted of  individuals from farms where 
cattle and/or goats tested positive for Brucella from 
an earlier survey in Mbarara district (south western 
Uganda – where 98 herds of  cattle and goats from 
three agro-ecological zones were studied - unpublished) 
and the second group included individuals recruited 
at HIV counseling  and  testing  clinic  in  Kampala 
who  answered  in  affirmative  for  consuming  un-
pasteurized  milk.  For  the  Mbarara  sample,  three 
teams  each  comprising  of     two  medical laboratory 
technicians under the supervision of  a medical doctor 
visited households where cattle and/or  goats  tested 
positive  for  Brucella  in  a  previous  study.    For  the 
Kampala  sample participants were asked to disclose 
their laboratory identification numbers for purposes of  
accessing  aliquots  of   their  blood  sample  used  in 
HIV  screening,  participants  were  also interviewed on 
their feeding habits and lifestyles.
Assuming Brucella sero-prevalence of  11.9%11,13 and 
18%8,10  for Mbarara and Kampala districts respectively, 
with a 95% confidence that the error in the estimate will 
not exceed 5% and using standard survey formula12,14, a 
total of  329 individuals were studied; 161 from Mbarara 
and 168 from Kampala. At least seven participants were 
sampled from each of  the 26 households that had cattle 
and goats that tested positive for Brucella. Blood was 
centrifuged and serum stored at -200C until it was tested 
using three tests – the buffered/Rose Bengal plate ag-
glutination test (RPAT), the standard tube agglutination 
test (STAT) and the competitive ELISA (cELISA) test 
at  Makerere  University’s  then  Faculty  of   Veterinary 
Medicine  (now  the  College  of  Veterinary Medicine, 
Animal Resources and Biosecurity, COVAB.
Ethical Issues
The rights of  the human participants were clearly ex-
plained to each one of  them. All participants signed 
consent  forms  written  in  their  own  local  language 
which  guaranteed  that  all  the information and sam-
ples collected were to be used only for the intended 
purpose, and their identify would  remain confidential. 
Ethical approval for the study was sought and granted 
by the Research and Ethics Committee of  Mbarara 
University of  Science and Technology (MUST) Medi-
cal School and the Uganda National Council of  Science 
and Technology (UNCST). The field team included 
qualified and registered medical laboratory technicians 
under the supervision of   two  medical  doctors  who 
were  charged  with  collecting serum samples from the 
human subjects.
Data handling and analysis
Serological Assay
All samples were tested by both the  buffered plate ag-
glutination test (BPAT) using febrile antigens and com-
petitive enzyme linked immunosorbent assay (cELISA). 
Samples that tested positive  on  the  BPAT  were  re-
tested  on  the  serum  tube  agglutination  test  (STAT) 
for confirmation. The febrile antigens multi-screening 
kits together with the positive and negative human con-
trol sera used in the agglutination tests were supplied 
by Human Gesellschaft fur Biochemia und Diagnostica 
mbH,   Germany. The cELISA kits were supplied by 
Veterinary Laboratories Agency (VLA) of  the Depart-
ment for Environment, Food and Rural Affairs, UK.
Buffered Plate Agglutination Test (BPAT)
The test was carried out as described by Lucero and 
Bolpe13,15. Briefly the test antigen together with the test 
and control sera were removed from the refrigerator 
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and allowed to thaw for about 30 minutes then mixed 
thoroughly but gently. Equal volumes of  50 ul for both 
the test serum and the antigen were placed side by side 
on separate cells of  the white slide. The antigen and test 
sera were then mixed with separate disposable sticks 
and the fluid spread over the entire area of  a particular 
cell. The slide was then rocked gently back and forth for 
up to 1 minute. The results were read under bright ar-
tificial light. Any sample with visible agglutination was 
designated positive.
 
Standard/Serum Tube Agglutination Test (STAT)
The  test  was  performed  as  previously  described  by 
Lucero  and  Bolpe13,15. Briefly,  all  test reagents and 
serum samples were thawed to room temperature and 
then mixed thoroughly but gently prior to use. Then 20 
ul of  each serum sample were diluted with 1.98 ul of  
NaCL (9g/l); six double dilutions were then made for 
each serum sample and the controls from 1/20 through 
1/640. One drop of  the antigen was then added to 
each of  the tubes. The tubes were closed, contents 
mixed thoroughly and incubated at 370C for 24 hours. 
The sample was categorized as positive if  there was a 
coarse, compact agglutination with clearing of  the su-
pernatant. 
The results were negative if  the supernatant was un-
changed in its appearance and showed a swirl when the 
tube was flicked. The highest dilution to give agglutina-
tion was recorded as the titer for that sample. However, 
any sample that showed agglutination at the dilution of  
1/20 and above was designated positive.
Competitive Enzyme Linked Assay (cELISA)
The test was performed as described by Nielsen and 
others14,16. Pre-coated 96 wells of  microtiter plates 
with B. melitensis LPS antigen (Veterinary Laboratory 
Agency, UK) were used. Briefly 20 ul of  each test se-
rum in duplicate was dispensed per well, leaving the 
last two columns for the controls (serum and conjugate 
controls). Immediately 100 ul of  the conjugate (Goat 
anti-mouse immunoglobulin G antibody conjugated to 
horseradish peroxidase diluted in phosphate buffer so-
lution) were dispensed into each well. After vigorously 
shaking for about 2 minutes on an automatic shaker, the 
plate was incubated for 30 minutes at room tempera-
ture on a rotary shaker. The plate was then washed 5 
times with Tween 20 and Na2HPO4 solution. 
Finally 100 ul of  the substrate (Urea hydrogen perox-
ide) and chromogen (OPD) mixture were added to each 
well and the plate left for 10–15 minutes at room tem-
perature. The reaction was then stopped with 100 ul of  
citric acid solution and the OD (Optic Density) of  the 
plate read with a microtiter plate reader at 450 nm. Lack 
of  colour development indicated a positive sample, as 
indicated by the colorless wells. A positive/negative cut 
off  was calculated as 60% of  the mean of  the opti-
cal density (OD) of  the 4 conjugate control wells. Any 
sample that gave an OD value equal to or below this cut 
off  value was regarded as positive.
Data collection and analysis 
A standard structured questionnaire was administered 
by personal interview to the sampled study individuals. 
This comprised data on host attributes like age, sex, reli-
gion and place of  residence. Data on milk feeding habits 
and contact with livestock were also collected. Raw data 
was entered, validated and stored in Microsoft Access 
(MS Office 2003, Microsoft®). Validated data was  then 
exported  to  Statistical  Package  for  Social  Science 
(SPSS  12.0  for  Windows)  for analysis. All the postu-
lated risk factors were first assessed for significance and 
their association with the disease outcome (cELISA test 
status of  a farm) by computing their respective odds ra-
tios and chi square values before  offeringfeeding them 
into a generalized linear mixed model (GLMM) 15 and 
executed in SAS IML macro (SAS institute Inc., version 
6, 1985)15,17 to further study the relationship between 
the postulated risk factors and the disease outcome for 
purposes of  identifying modifiable ones. Significance 
at initial screening and for the final model was set at 
p<0.25 and p<0.05, respectively.
Results 
Descriptive statistics
The majority (62.6%, n=329) of  the study group were 
male; this proportional difference was reflected in the 
two District, Kampala and Mbarara. The Kampala 
population was older than that of  Mbarara with average 
of  31 years and 29 years (Median 29 years vs. 23years), 
respectively.
Overall, the majority (69.3%, n=329) of  people inter-
viewed took milk at least once every day  with  those  in 
Mbarara  District  taking  significantly  (p<0.05)  more 
milk  than  Kampala (85.5%, 95%CI 90.9,80.1 vs 53.6%, 
95%CI 61.1,46.1). Consumption of  un-boiled milk re-
mained a common practice especially in Mbarara than 
in Kampala Districts (37.9% vs 16.7%) but was not sig-
nificantly deifferent. The prevalence of  brucellosis-like 
symptoms (prolonged fevers not responding to antima-
larial treatment) among the individuals interviewed was 
Individual Brucella sero-prevalence
The overall sero-prevalence on screening with BPAT at 
individual level was 15.2% (n=329 samples) of  which 
19 (5.8%, n=329) were confirmed positive at a STAT 
titer of  1:20 and above. However, cELISA test found 
16 (4.9%, n=329) samples positive (Table 2). The pro-
portion of  individuals with Brucella antibodies on all 
the three tests (BPAT, STAT and cELISA) were higher 
in Mbarara than in Kampala Districts (Table 2). 
Table 1: Distribution of hypothesized risk factors by District 
 
                                                No                   78.6(132)        60.2(97)          69.6(229)   
Table 2:Individual level sero-prevalence based on BPAT, STAT, cELISA and 
STAT+cELISA by District. 
Area               No sampled                            Seroprevalence %±SE(p) 
                                              RBT              STAT            cELISA        STAT/cELISA   
Mbarara 161 18.0 ± 0.03 7.5± 0.02 9.3± 0.02 13.0±0.03 
Kampala 168 12.5± 0.03 4.2 ± 0.02 0.6 ± 0.005 4.8 ± 0.02 
 
Total                329                  15.2 ± 0.02      5.8 ± 0.01        4.9 ± 0.01        8.8± 0.02   
 
Although 19 of  329 samples (5.8%) gave positive results 
with STAT titers of  1/20, Table 2 shows that although 
sero-positivity at different dilutions appeared higher in 
Mbarara compared to Kampala Districts, significant dif-
ference was shown with cELISA only. In addition, there 
was a significant (p<0.05) difference in the number of  
people with titers >1/160 in Mbarara than in Kampala 
samples (Table 3).
high at 81.2% (n=325). This contrasted with the poor 
knowledge of  human brucellosis among the people, 
where 69.6% (n=329) of  all the people interviewed had 
never heard of  the disease (Table 1)
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 Variable Levels Kampala 
%(n=168) 
Mbarara 
%(n=161) 
Overall 
%(n=325) 
Sex Female 38.7(65) 36(58) 37.4(123) 
 Male 61.3(103) 64(103) 62.6(206) 
 
Milk consumption 
frequency 
 
At least 
once/day 
 
 
53.6(90) 
 
 
85.7(138) 
 
 
69.3(228) 
 Less than 
once/day 
 
46.3(78) 
 
14.3(23) 
 
30.7(101) 
Consumption of 
un-boiled milk 
 
Yes 
 
16.7(28) 
 
37.9(55) 
 
26.5(83) 
 
Contact with 
No 83.3(140) 62(90) 73.5(230) 
Animals Yes 17.3(29) 93.2(150) 54.4(179) 
 
History of brucellosis- 
No 82.7(139) 6.8(11) 45.6(150) 
like symptoms 12months 
preceding study 
 
Yes 
 
88.7(149) 
 
71.4(115) 
 
81.2(264) 
 
Human brucellosis 
No 8.9(15) 28.6(46) 18.8(61) 
awareness Yes 21.4(36) 39.8(64) 30.4(100) 
*For Mbarara, n=145
** For Kampala n=164; Overall total (n=325)
When individuals were re-classified according to react-
ing positively on both STAT and cELISA tests, in an at-
tempt to improve sensitivity, 8.8% (29/329) were sero-
positive. Sero-prevalence differed between the Mbarara 
and Kampala groups (Table 2).
Rrisk factors associated with Brucella sero-positiv-
ity.
In order to improve the sensitivity of  the two tests 
(STAT and cELISA), individuals were re classified  as 
being  positive  if   one  gave  a  positive  result  on 
any  of   the  two  tests  i.e. interpretation  in  parallel. 
Univariate  univariable  analysis  showed  that  the  con-
sumption  of  unboiled milk was significantly (p=0.004) 
associated with seropositivity in Mbarara District. No 
significant difference was found between the age, sexes 
and human brucellosis awareness both in Mbarara and 
Kampala Districts (p >0.05) (Table 4).
Female 58 10.3 (6) p= 0.44 
Male 103 14.6(15)  
Kampala 
Female 
 
65 
 
7.7(5) 
 
p= 0.26 
Male 103 2.9(3)  
 
Table 4: Distribution of sero-positivity by hypothesized risk factors and district. 
 
Variable/District           Frequency        Seropositive cases (%)              p – value 
                                                                  STAT/cELISA   
 
Sex 
Mbarara
 
Age 
Mbarara 
<29yrs 
 
99 
 
10.0(10) 
 
p= 0.30 
>29yrs 62 17.7(7)  
Kampala 
<31yrs 
 
100 
 
6.0(6) 
 
p= 0.15 
>31yrs 68 2.9(2)  
Consumption of 
unboiled milk 
   
Mbarara 
Yes 
 
55 
 
23.6(13) 
 
p= 0.004* 
No 90 7.8(7)  
Kampala 
Yes 
 
28 
 
3.6(1) 
 
p= 0.99 
No 140 5.0(7)  
Knowledge of 
human brucellosis 
Mbarara 
Yes 
 
64 
 
10.9(7) 
 
p= 0.52 
No 97 14.4(14)  
Kampala 
Yes 
 
36 
 
2.7(1) 
 
p= 0.99 
             No                      132                     5.3(7)   
 
 
Discussion
This study has shown that overall, the STAT sero-prev-
alence of  human brucellosis among cattle keepers in 
Mbarara and consumers of  milk in Kampala was 5.8%. 
This observation agrees closely with  other studies –  an 
earlier study, one in a big hospital in Kampala among fe-
brile patients  and  another  among abattoir  workers  in 
Kampala  and  Mabrara   that  reported  sero-prevalences 
of  13%  and 10%, respectively,9. Three percent (4/161) 
of  the STAT positive people in Mbarara District had 
high antibody titers (>1/160), which was indicative of  
active infection. These four people with high STAT tit-
ers were also experiencing brucellosis-like clinical signs 
suggesting acute brucellosis infection. Although no sin-
gle test provides 100% specificity and sensitivity, STAT 
remains the test of  choice in diagnosis. In the presence 
of  appropriate signs and symptoms, a presumptive di-
agnosis of  brucellosis is usually defined  serologically 
as  a  standard  tube  agglutination  titer  of   1:160 
or  greater16,18. This is however time-consuming, be it in 
sero-epidemiological studies,where a large number of  
sera samples have to be processed or in hospital/medi-
cal laboratories, where treatment of  brucellosis patients 
has  to  be  commenced  soon.  Therefore,  other  less 
laborious  and  faster  turn-around diagnostic tests like 
competitive enzyme-linked immunoassay (cELISA) are 
currently used in the diagnosis of  human diagnosis17,19. 
cELISA has the advantage of  being fairly rapid to per-
form, somewhat faster than STAT, and cross-reacts 
less with other antigens (or antibodies) than the con-
ventional tests. In the current study the sero-prevalence 
obtained by STAT was not different (p<0.05) from that 
for cELISA.
Data on the sero-prevalence of  human brucellosis in 
developing countries is very limited indeed. Previous 
studies carried out predominantly in the Mediterranean 
region have reported sero-prevalence estimates ranging 
from 8% in Jordan18,20  to 15% in Saudi Arabia19,21. In 
sub- Saharan Africa sero-prevalence estimates of  5.3% 
in Nigeria20,22 and  10%-13.3% in Uganda7,6,9 have been 
reported.
Isolation of  Brucella microorganisms by blood cultures 
is confirmatory of  brucellosis; however in practice it is 
difficult because of  early tissue localization of  the bacte-
ria and the exacting  culture  requirements.  In  practice, 
blood  cultures  are  positive  in  10%  -  30%  of  brucel-
losis cases16,18, and the remainder is diagnosed serologi-
cally. None the less brucellosis diagnosis particularly in 
endemic areas poses enormous challenges. Past studies 
have reported a low specificity for the commonly used 
serological tests (RBT and STAT) in endemic areas and 
in  patients  with  a  long  history  of   brucellosis17,19, 
21,23.  Competitive  enzyme  immunoassay (cELISA) has 
high specificity and sensitivity (99.7% and 98.3), and is 
useful for evaluating treatment effectiveness, for moni-
toring clinical conditions, and for prognosis17. In the 
present study sera were screened by PBAT, followed by 
STAT as the confirmatory test. 
In addition opportunities to diagnose brucellosis with 
cELISA were also explored.
In order to improve the sensitivity of  the two tests 
(STAT and cELISA), individuals were reclassified  as 
being  positive  if   one  gave  a  positive  result  on  any 
of   the  two  tests  i.e. interpretation in parallel. Using 
this criterion, 29 out of  329 sera samples (9%) were 
positive. Basing  on  this  classification  consumption 
of   unboiled  milk  was  significantly  (p=  0.004)
associated with sero-positivity in Mbarara District. This 
is in agreement with other studies22,24. In Kampala Dis-
trict unlike Mbarara, there was no significant (p=0.99) 
difference in Brucella seropositivity between consum-
ers of  unboiled raw milk and those who do not. This 
may be that freshly drawn milk which the consumers 
in Mbarara District commonly take is more infective 
compared  their  Kampala  counterparts  who  are 
most  likely  to  consume  adulterated  milk. Moreo-
ver the study has shown that the proportion of  peo-
ple who consume larger quantities of  milk per day, (i.e 
> 500mL/day), is higher in Mbarara than in Kampala 
Districts (85% vs. 28%).
Conclusion
This study has clearly demonstrated that human brucel-
losis is still prevalent and that consumption of  unboiled 
raw milk continues to be practiced despite the risk it 
poses to human health due to brucellosis. This study 
found no significant association (p>0.05) with age and 
sex and brucella sero-status. This calls for immediate 
and deliberate efforts by the authorities to institute pre-
vention and control measures. The most effective way 
to control the disease in man is by elimination of  the 
infected animals, and vaccination of  the health ones in 
order to reduce the risk of  those in regular contact with 
animals, and to produce brucellosis free animal prod-
ucts.  Avoiding consumption of  raw milk and proper 
heat treatment of  milk is important for effective pre-
vention of  the disease in humans. However local cus-
toms like those encouraging consumption of  freshly 
drawn milk (locally called amakamo in Mbarara district) 
is a challenge and  may  greatly hinder  wide  application 
of   such  measures.  Consequently health  education 
should  always  be  an integral part of   every phase  of  
disease  prevention and control.  Close cooperation and 
joint supervision between the ministries of  Health and 
Agriculture, Animal Industries and Fisheries should be 
encouraged.
Acknowledgements
The study was supported in part by a grant from CIRAD 
and Makerere University, Kampala- Uganda for which 
we are grateful.
                
                    
794
                 
                    
795African Health Sciences Vol 14 Issue 4, December 2014 African Health Sciences Vol 14 Issue 4, December 2014
Table  3:  Distribution  of   STAT  titers  in  the  study  area.   
 
Area No sampled 
(n) 
 
1/20 
STAT titers (%, 95%CI) 
>1/40 
 
>1/160 
Mbarara 161 7.5 (8.3, 3.4) 3.7 (6.6, 0.8) 2.5 (4.9, 0.1) 
Kampala 168 4.2 (7.2, 1.2) 1.8 (3.8, 0.0) 0.0 (0, 0) 
 
Total                329                  5.8 (8.3, 3.3)   2.7 (4.4, 1.0)               1.2 (2.4, 0.0)   
 
*
* For Mbarara  n=145
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